Abstract
The objective of this study was to compare the frequency and severity of neurologic manifestations in adult patients diagnosed with thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS) and atypical HUS (aHUS). This is a retrospective cohort study of adult patients diagnosed with TTP, HUS and atypical HUS hospitalized at a tertiary center between January 2004 and October 2016. A total of 42 TTP, 16 HUS and 20 aHUS episodes were reviewed to collect clinical, laboratory and radiographic data, as well as information regarding long-term functional outcome. Neurologic symptoms are more common in patients with TTP and HUS as compared to aHUS (p < 0.001 and p = 0.002, respectively). Encephalopathy occurred in 29 TTP (69%) and 11 HUS (68%) episodes. Focal deficits were only observed in patients with TTP (n = 8 [19%]). Seizures were most commonly seen in HUS patients (n = 8 [50%]). Posterior reversible encephalopathy syndrome (PRES) was the most common neuroimaging finding in these syndromes; ischemic infarcts and hemorrhages occurred uncommonly. There was no correlation between presence of neurologic symptoms or neuroimaging abnormalities and poor outcome. Patients with TTP and HUS appear to have a similar spectrum of neurologic manifestations, whereas neurologic involvement is less common in aHUS. PRES is the most common imaging abnormality, and may present atypically. Despite presence of neurologic symptoms or neuroimaging abnormalities, patients with thrombotic microangiopathy (TMA) tend to have favorable long-term outcomes.
Similar content being viewed by others
Data availability
Anonymized data can be made available for review upon reasonable request from qualified investigators.
References
George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371(7):654–666. https://doi.org/10.1056/nejmra1312353
Zheng XL, Sadler JE (2008) Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol Mech Dis 3:249–277
Sadler JE (2008) Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 112(1):11–18. https://doi.org/10.1182/blood-2008-02-078170
Loirat C, Frémeaux-Bacchi V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6:60–60. https://doi.org/10.1186/1750-1172-6-60
Noris M, Remuzzi G (2009) Atypical hemolytic–uremic syndrome. N Engl J Med 361(17):1676–1687. https://doi.org/10.1056/nejmra0902814
Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, Brun M, Ranchin B, Bandin F, Cloarec S, Bourdat-Michel G, Piètrement C, Champion G, Ulinski T, Deschênes G (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5(7):1218–1228. https://doi.org/10.2215/cjn.08921209
Siegler RL (1994) Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr 125(4):511–518. https://doi.org/10.1016/S0022-3476(94)70001-X
Toldo I, Manara R, Cogo P, Sartori S, Murer L, Battistella PA, Laverda AM (2008) Diffusion-weighted imaging findings in hemolytic uremic syndrome with central nervous system involvement. J Child Neurol 24(2):247–250. https://doi.org/10.1177/0883073808323022
Banatvala N, Griffin PM, Greene KD, Barrett TJ, Bibb WF, Green JH, Wells JG (2001) The United States national prospective hemolytic uremic syndrome study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 183(7):1063–1070. https://doi.org/10.1086/319269
Magnus T, Röther J, Simova O, Meier-Cillien M, Repenthin J, Möller F, Gbadamosi J, Panzer U, Wengenroth M, Hagel C, Kluge S, Stahl RK, Wegscheider K, Urban P, Eckert B, Glatzel M, Fiehler J, Gerloff C (2012) The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain 135(6):1850–1859. https://doi.org/10.1093/brain/aws090
Takanashi JI, Taneichi H, Misaki T, Yahata Y, Okumura A, Ishida YI, Miyawaki T, Okabe N, Sata T, Mizuguchi M (2014) Clinical and radiologic features of encephalopathy during 2011 E. coli O111 outbreak in Japan. Neurology 82(7):564–572. https://doi.org/10.1212/wnl.0000000000000120
Weissenborn K, Donnerstag F, Kielstein JT, Heeren M, Worthmann H, Hecker H, Schmitt R, Schiffer M, Pasedag T, Schuppner R, Tryc AB, Raab P, Hartmann H, Ding XQ, Hafer C, Menne J, Schmidt BMW, Bultmann E, Haller H, Dengler R, Lanfermann H, Giesemann AM (2012) Neurologic manifestations of E. coli infection-induced hemolytic-uremic syndrome in adults. Neurology 79(14):1466–1473. https://doi.org/10.1212/wnl.0b013e31826d5f26
Wengenroth M, Hoeltje J, Repenthin J, Meyer TN, Bonk F, Becker H, Faiss S, Stammel O, Urban PP, Bruening R (2013) Central nervous system involvement in adults with epidemic hemolytic uremic syndrome. Am J Neuroradiol 34(5):1016–1021. https://doi.org/10.3174/ajnr.a3336
Piercefield EW, Bradley KK, Coffman RL, Mallonee SM (2010) Hemolytic uremic syndrome after an Escherichia coli O111 outbreak. Arch Intern Med. https://doi.org/10.1001/archinternmed.2010.346
Gulleroglu K, Fidan K, Hançer VS, Bayrakci U, Baskin E, Soylemezoglu O (2013) Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab. Pediatr Nephrol 28(5):827–830. https://doi.org/10.1007/s00467-013-2416-9
Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120(4):c179–c184. https://doi.org/10.1159/000339789
Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN (2017) Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv 1(10):590–600. https://doi.org/10.1182/bloodadvances.2017005124
Blombery P, Kivivali L, Pepperell D, McQuilten Z, Engelbrecht S, Polizzotto MN, Phillips LE, Wood E, Cohney S, on behalf of the TTPrsc (2016) Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry. Intern. Med. J.l 46(1):71–79. https://doi.org/10.1111/imj.12935
Steinborn M, Leiz S, Rüdisser K, Griebel M, Harder T, Hahn H (2004) CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr Radiol 34(10):805–810. https://doi.org/10.1007/s00247-004-1289-2
Koehl B, Boyer O, Biebuyck-Gougé N, Kossorotoff M, Frémeaux-Bacchi V, Boddaert N, Niaudet P (2010) Neurological involvement in a child with atypical hemolytic uremic syndrome. Pediatr Nephrol 25(12):2539–2542. https://doi.org/10.1007/s00467-010-1606-y
Burrus TM, Wijdicks EFM, Rabinstein AA (2009) Brain lesions are most often reversible in acute thrombotic thrombocytopenic purpura. Neurology 73(1):66–70. https://doi.org/10.1212/WNL.0b013e3181aaea1b
Bakshi R, Shaikh ZA, Bates VE, Kinkel PR (1999) Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients. Neurology 52(6):1285. https://doi.org/10.1212/WNL.52.6.1285
Petz LDJS (1977) Neurological manifestations of systemic lupus erythematosus and thrombotic thrombocytopenic purpura. Stroke 8(6):719–722
Hagel C, Krasemann S, Löffler J, Püschel K, Magnus T, Glatzel M (2015) Upregulation of Shiga toxin receptor CD77/Gb3 and interleukin-1β expression in the brain of EHEC patients with hemolytic uremic syndrome and neurologic symptoms. Brain Pathol 25(2):146–156. https://doi.org/10.1111/bpa.12166
Takahashi K, Funata N, Ikuta F, Sato S (2008) Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. J Neuroinflammation 5(1):11. https://doi.org/10.1186/1742-2094-5-11
Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14(9):914–925. https://doi.org/10.1016/S1474-4422(15)00111-8
Burrus TM, Mandrekar J, Wijdicks EFM, Rabinstein AA (2010) Renal failure and posterior reversible encephalopathy syndrome in patients with thrombotic thrombocytopenic purpura. Arch Neurol. https://doi.org/10.1001/archneurol.2010.119
Schuppner R, Maehlmann J, Dirks M, Worthmann H, Tryc AB, Sandorski K, Bahlmann E, Kielstein JT, Giesemann AM, Lanfermann H, Weissenborn K (2016) Neurological sequelae in adults after E. coli o104: h4 infection-induced hemolytic-uremic syndrome. Medicine (Baltimore) 95(6):e2337. https://doi.org/10.1097/md.0000000000002337
Funding
This research received no specific funding.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Data collection, data analysis and manuscript preparation were performed by EW. Interpretation of data and critical revisions of the manuscript were performed by AR. All authors have approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to disclose, financial or otherwise.
Ethical approval
This study has been performed in accordance with ethical standards laid down in the 1964 Declaration of Helsinki.
Consent to participate
Written informed consent was waived due to the retrospective nature of the study. All data was anonymized.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Weil, E.L., Rabinstein, A.A. Neurological manifestations of thrombotic microangiopathy syndromes in adult patients. J Thromb Thrombolysis 51, 1163–1169 (2021). https://doi.org/10.1007/s11239-021-02431-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-021-02431-5